Susquehanna International Group, LLP Ab Cellera Biologics Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 417,396 shares of ABCL stock, worth $980,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
417,396
Previous 234,064
78.33%
Holding current value
$980,880
Previous $606,000
101.65%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ABCL
# of Institutions
165Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$64.7 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$28.8 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$25 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$18.6 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$17.3 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $670M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...